نتائج البحث

Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease

• Source: A Single-arm Multi-center Study of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft Versus Host

تفاصيل العنوان

Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

• Authors : National Institutes of Health (NIH); National Center for Advancing Translational Sciences (NCATS)

• Source: A Phase 1/2 Multi-Center Trial of Vorinostat for Graft vs Host Disease

تفاصيل العنوان

Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant (REACH 5)

• Source: A Phase II Open-label, Single-arm, Multi-center Study of Ruxolitinib Added to Corticosteroids in Pediatric Subjects With Moderate and Severe Chronic Graft

تفاصيل العنوان

Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease

• Source: A Single-arm, Multi-center Study of Ruxolitinib for the Treatment of Chinese Patients With Grade II-IV Corticosteroid-refractory Acute Graft Versus

تفاصيل العنوان

Upfront Ruxolitinib for Chronic Graft-vs-host Disease

• Source: Upfront Ruxolitinib Treatment for Chronic Graft-vs-host Disease in Children

تفاصيل العنوان

Tacrolimus Toothpaste for Management of Oral Chronic Graft vs. Host Disease (cGVHD)

• Source: Prospective Study of Tacrolimus Toothpaste for Management of Oral Chronic Graft vs. Host

تفاصيل العنوان

Study of Pharmacokinetics, Activity and Safety of Ruxolitinib in Pediatric Patients With Grade II-IV Acute Graft vs. Host Disease

• Source: A Phase I/II Open-label, Single-arm, Multi-center Study of Ruxolitinib Added to Corticosteroids in Pediatric Patients With Grade II-IV Acute Graft

تفاصيل العنوان

A Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002) (2002)

• Authors : National Heart, Lung, and Blood Institute (NHLBI); Blood and Marrow Transplant Clinical Trials Network; National Cancer Institute (NCI)

• Source: A Phase 3, Randomized, Open-Label, Multicenter Study, to Compare T-Guard to Ruxolitinib for the Treatment of Patients With Grade III or IV Steroid-Refractory Acute

تفاصيل العنوان

A Phase II Pediatric Study of a Graft-VS.-Host Disease (GVHD) Prophylaxis Regimen With no Calcineurin Inhibitors After Day +60 Post First Allogeneic Hematopoietic Cell Transplant for Hematological Malignancies

• Source: A Phase II Pediatric Study of a Graft-VS.-Host Disease (GVHD) Prophylaxis

تفاصيل العنوان

Body Composition Assessment Provides Prognostic Information in Patients With Cancer Affected by Chronic Graft vs. Host Disease

• Authors : Asmita Mishra; Ram Thapa; Kevin Bigam

Subjects: abdominal visceral fat; graft vs. host disease; sarcopenia

• Source: Journal of Cachexia, Sarcopenia and Muscle, Vol 16, Iss 2, Pp n/a-n/a (2025)

تفاصيل العنوان